Drug Database
Back to search

Belgium· BE-AMP-SAM598924-00

Enbrel 50 mg

A etanercept product containing etanercept, registered in Belgium by Pfizer Europe MA. The same ATC class is registered in 14 of our 19 countries.

ATC L04AB01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEnbrel 50 mgATCL04AB01REGISTER NO.BE-AMP-SAM598924-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about etanerceptAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Etanercept is registered in 14 of 19 countries.

Countries holding a registration under ATC L04AB01 (etanercept), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search etanercept products by name

Etanercept · ATC L04AB01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etanercept costs, country by country.

Normalised to the WHO defined daily dose (7 mg), the median price runs from $0.35 in Finland to $35.22 in Switzerland — a ×100 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Etanercept · price per daily dose (7 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$35.22
  • FI Finland$0.35
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Etanercept
Manufacturer
Pfizer Europe MA
Country
Belgium (BE)
ATC code
L04AB01
ATC class
Etanercept
Defined daily dose
7 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    4521043
    EUR 1311.9
  • be_apb
    4521050
    EUR 463.46
  • be_apb
    7736903

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

429 interactions on record for etanercept.

Graded by severity as the source publishes them — 287 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check etanercept against other medicinesHow interaction checks work

Etanercept · interactions on record

429 records

  • 287 severe
  • 135 moderate
  • 7 minor

Most severe, free to view

  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • BetamethasoneA07EA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etanercept in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etanercept products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Enbrel, Enbrel For Paediatric Use
  • Liechtenstein · Enbrel, Enbrel For Paediatric Use
  • Norway · Enbrel, Enbrel For Paediatric Use

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebe8fc6c-7f0a-4a13-b28e-9ca75e8ed39b
GET /v1/drugs/ebe8fc6c-7f0a-4a13-b28e-9ca75e8ed39b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in dose-dispenser cartridge",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Enbrel 50 mg",
  "name_fr": "Enbrel 50 mg",
  "name_nl": "Enbrel 50 mg",
  "amp_code": "SAM598924-00",
  "strengths": [
    "50.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Etanercept",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Sodium Chloride",
    "Sodium Dihydrogen Phosphate Dihydrate",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Etanercept",
  "authorisation_numbers": [
    "EU/1/99/126/030",
    "EU/1/99/126/032",
    "EU/1/99/126/031"
  ]
}
API referenceMCP serverPlans

See everything about etanercept.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console